Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial

BMC Gastroenterology

Boram Park¹  Jong Yeul Lee²  Il Ju Choi²  Young-Il Kim²  Chan Gyoo Kim²  Jin Young Park³ 

[1] Biostatistics Collaboration Team, Research Core Center, Research Institute, National Cancer Center, 10408, Goyang, Korea;Center for Gastric Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, 10408, Goyang, Gyeonggi, South Korea;Prevention and Implementation Group, International Agency for Research on Cancer, 69372, Lyon, France;

关键词: Helicobacter pylori;    Quadruple therapy;    Triple therapy;   

DOI  :  10.1186/s12876-021-01680-1

来源: Springer

【 授权许可】

CC BY